Search Results Search Sort by RelevanceMost Recent In the Literature Oct 2018 Why Marginalization, Not Vulnerability, Can Best Identify People in Need of Special Medical and Nutrition Care Alexis K. Walker, PhD and Elizabeth L. Fox, PhD Focusing on social processes contributing to marginalization can help clinicians and policy makers mitigate food insecurity risk through improved patient-centered care. AMA J Ethics. 2018;20(10):E941-947. doi: 10.1001/amajethics.2018.941. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. AMA Code Says Dec 2017 AMA Code of Medical Ethics’ Opinions Related to Climate Change Annalise Norling The AMA Code of Medical Ethics’ opinions related to climate change. AMA J Ethics. 2017;19(12):1183-1185. doi: 10.1001/journalofethics.2017.19.12.coet1-1712. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. History of Medicine May 2020 What Does the Evolution From Informed Consent to Shared Decision Making Teach Us About Authority in Health Care? James F. Childress, PhD and Marcia Day Childress, PhD Reliance on disclosure rather than understanding has prompted shared decision making and represents an important cultural change in clinical practice. AMA J Ethics. 2020;22(5):E423-429. doi: 10.1001/amajethics.2020.423. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
In the Literature Oct 2018 Why Marginalization, Not Vulnerability, Can Best Identify People in Need of Special Medical and Nutrition Care Alexis K. Walker, PhD and Elizabeth L. Fox, PhD Focusing on social processes contributing to marginalization can help clinicians and policy makers mitigate food insecurity risk through improved patient-centered care. AMA J Ethics. 2018;20(10):E941-947. doi: 10.1001/amajethics.2018.941.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
AMA Code Says Dec 2017 AMA Code of Medical Ethics’ Opinions Related to Climate Change Annalise Norling The AMA Code of Medical Ethics’ opinions related to climate change. AMA J Ethics. 2017;19(12):1183-1185. doi: 10.1001/journalofethics.2017.19.12.coet1-1712.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
History of Medicine May 2020 What Does the Evolution From Informed Consent to Shared Decision Making Teach Us About Authority in Health Care? James F. Childress, PhD and Marcia Day Childress, PhD Reliance on disclosure rather than understanding has prompted shared decision making and represents an important cultural change in clinical practice. AMA J Ethics. 2020;22(5):E423-429. doi: 10.1001/amajethics.2020.423.